Press releases

(May 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved extending the shelf life of its TAXUS® Express2™...

(May 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR),...

and Chicago, IL (May 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results of four clinical trials demonstrating patient satisfaction with, and effectiveness of, the ENTERYX®

(May 12, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Banc of America Securities Health Care Conference 2005, which is being held May 17-19 in Las Vegas....

(April 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 30th Annual Health Care Conference, which is being held May 2-4 in Baltimore,...

(April 27, 2005) -- Boston Scientific (NYSE: BSX) today announced one-year data from its carotid artery stenting (CAS) clinical trial known as BEACH. The study evaluates the effectiveness of...

(April 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that six articles related to its pivotal TAXUS IV clinical trial were published in the April 19 edition of the...

(April 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its first quarter ended March 31, 2005. Highlights: Net sales of $1.6 billion, an increase of 49...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired TriVascular, Inc., a privately held company based in Santa Rosa, California. Boston Scientific...

(April 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has exercised its option to acquire CryoVascular Systems, Inc., a privately held company located in Los Gatos,...